Wall Street Financial Group’s Insmed INSM Stock Holding History

Wall Street Financial Group’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-38	Closed	-$6.21K	–	361
2026 Q1	$6.21K	Buy	+38	New	+$5.84K	﹤0.01%	491

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Wall Street Financial Group's INSM Position: Q2 2026 in Review

Wall Street Financial Group sold out of Insmed (INSM) in Q2 2026, closing a stake of 38 shares — an estimated $6.21K sold.

Wall Street Financial Group first reported a position in INSM in Q1 2026 and held it in 1 quarter. The position peaked at $6.21K in Q1 2026. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Wall Street Financial Group reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
Wall Street Financial Group sold 38 Insmed shares in Q2 2026, an estimated $6.21K.
Wall Street Financial Group first reported a position in Insmed in Q1 2026 and held it in 1 quarter.
Wall Street Financial Group's Insmed position peaked at $6.21K in Q1 2026.
667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Wall Street Financial Group's 13F filing for Q2 2026, filed 14 Jul 2026.